Investor Hub
Novavax, Inc. is a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases.
Latest investor presentation
Annual report
Latest publications, posters & presentations
Global ticker
NASDAQNVAX
SEC
Access filings by selecting the date range and type using the drop-down menus.
NASDAQNVAX
Year
Type
| Form | Description | Date | Format |
|---|---|---|---|
| 10-K405 | Annual report. The Regulation S-K Item 405 box on the cover page is checked | Apr 15, 1999 |  Open Annual report. The Regulation S-K Item 405 box on the cover page is checked in HTML. Open Annual report. The Regulation S-K Item 405 box on the cover page is checked in DOC file. Open Annual report. The Regulation S-K Item 405 box on the cover page is checked in PDF file. Open Annual report. The Regulation S-K Item 405 box on the cover page is checked in XLS file. |
| NT 10-K | Notification that form 10-K will be submitted late | Apr 1, 1999 | Open Notification that form 10-K will be submitted late in HTML.Open Notification that form 10-K will be submitted late in DOC file.Open Notification that form 10-K will be submitted late in PDF file.Open Notification that form 10-K will be submitted late in XLS file. |
Why invest with us
 |
Get notifications for investor updates
Sign up for notifications from Novavax including upcoming events, webcasts, research updates, daily stock closings, SEC filings, and more.
Investor inquiries
 |
Shareholders seeking information can contact investor relations at (240) 268-2022 or email us at ir@novavax.com
Novavax corporate policy prohibits any employees, other than designated spokespersons, from communicating with its investors.